And a little further comment on this price point:
So, if Nasdaq is $3.00 minimal listing requirements -- and this all assumes, of course, that we actually get approved by Nasdaq for listing -- then I will personally *only* buy HLIX below .30.
And a $3.00 *minimal* Nasdaq price in my clean 20M OS estimate, that would be a $60M market cap with at most $15M in sales this year without the guard. And there is no evidence that MOR will be bringing any revenue with that, just alleged competitive advantages. So, I'll give that a p/s ratio of 4 on Nasdaq minimal listing. Which is getting high for the HLIX eqiuvalent of 30 cents, and a lot better than what KERN is looking like lately.
So, there you have it.
Whatsup, please don't interrupt me again when I'm thinking.
